Cigna Group (CI)

Over the past six months, The Cigna Group's stock price has experienced a decline of 11.09% as of April 12, 2026, and a 1-year decline of 11.4% as of April 9, 2026. Key events impacting the stock include better-than-expected Q4 2025 earnings, a finalized 2.48% Medicare Advantage payment rate increase for 2027, the announcement of David M. Cordani's retirement as CEO, a class action lawsuit filed against Express Scripts, and UBS naming Cigna Group a top healthcare pick.

Demand for Cigna's health insurance products exhibits seasonality, largely driven by annual open enrollment periods and employer renewal cycles. Healthcare spending, particularly out-of-pocket expenses, is generally highest in the first quarter and lowest in the fourth quarter. PBM services are driven by the continuous need to control escalating healthcare costs and the rising incidence of chronic diseases, with some seasonal demand impacting retail pharmacy pricing.

The Cigna Group is a global health services company that operates within the Healthcare sector, offering a range of insurance and related products and services through its Evernorth Health Services and Cigna Healthcare segments. It provides medical, dental, disability, life, and accident insurance, as well as pharmacy benefit management, specialty pharmacy services, and care services.

The Cigna Group has a significant global presence, serving over 185 million customer relationships in more than 30 countries and jurisdictions worldwide. While primarily operating in the United States, its international health operations and sales offices extend across North America, Europe, Asia, and the Middle East. Cigna Healthcare offers individual and family medical plans in 11 U.S. states and dental plans in 49 states. International operations for organizations and Africa are headquartered in Belgium, with additional offices in Miami, Spain, Kenya, and Malaysia.

In the past year, The Cigna Group's brand reputation has been impacted by a Medicare Advantage settlement where Cigna agreed to pay over $172 million to settle federal claims, a class-action lawsuit alleging the company used an algorithmic system to systematically deny medical claims, and a data breach that exposed patient data.

The Cigna Group is primarily owned by institutional investors, who collectively hold approximately 89% to 91% of the company's total shares outstanding. Major institutional shareholders include Vanguard Group Inc, BlackRock, Inc., State Street Corp, Massachusetts Financial Services Co, Fmr Llc, Dodge & Cox, Sanders Capital, LLC, GQG Partners LLC, Price T Rowe Associates Inc, and Geode Capital Management, Llc. Insiders own less than 1% of the company, while retail investors hold around 9% to 10% of the shares.